Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery

Br J Pharmacol. 2003 Apr;138(7):1320-32. doi: 10.1038/sj.bjp.0705160.

Abstract

1. The nonpsychoactive cannabinoid abnormal-cannabidiol (trans-4-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) (abn-cbd) produced concentration-dependent relaxation of methoxamine-precontracted rat small mesenteric artery. Endothelial removal reduced abn-cbd potency six-fold without affecting the maximum relaxation. 2. In endothelium-intact vessels, abn-cbd was less potent under 60 mM KCl-induced tone and inhibited by combination of L-N(G)-nitroarginine methyl ester (L-NAME) (nitric oxide synthase inhibitor; 300 micro M), apamin (small conductance Ca(2+)-activated K(+) channels inhibitor; 50 nM) and charybdotoxin (inhibitor of intermediate conductance Ca(2+)-activated K(+) channels and large conductance Ca(2+)-activated K(+) channels BK(Ca); 50 nM). L-NAME alone or in combination with either toxin alone had little effect. 3. In intact vessels, relaxations to abn-cbd were inhibited by SR 141716A (cannabinoid receptor antagonist; 1 or 3 micro M). Concomitant addition of L-NAME, apamin and charybdotoxin had no further effect. Other cannabinoid receptor antagonists either had little (SR 144528; 1 micro M and AM 251; 1 micro M) or no effect (AM 630; 10 micro M and AM 281; 1 micro M). Inhibition of gap junctions, G(i/o) protein coupling and protein kinase A also had no effect. 4. Endothelium-independent relaxation to abn-cbd was unaffected by L-NAME, apamin plus charybdotoxin or capsaicin (10 micro M). Abn-cbd inhibited CaCl(2)-induced contractions in vessels with depleted intracellular Ca(2+) stores and stimulated with methoxamine or KCl. This was insensitive to SR 141716A (3 micro M) but greatly reduced in vessels stimulated with ionomycin (Ca(2+) ionophore; 1 micro M). 5. We conclude that abn-cbd relaxes the rat small mesenteric artery by endothelium-dependent activation of K(+) channels via SR 141716A-sensitive pathways, which do not involve CB(1) and CB(2) receptors. It also causes endothelium-independent, SR 141716A-insensitive, relaxation by inhibiting Ca(2+) entry through voltage-gated Ca(2+) channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium Channels / drug effects
  • Calcium Chloride / pharmacology
  • Camphanes / pharmacology*
  • Cannabidiol / pharmacology*
  • Cannabinoid Receptor Antagonists*
  • Dose-Response Relationship, Drug
  • Endothelium-Dependent Relaxing Factors / pharmacology*
  • Gap Junctions / physiology*
  • Heterotrimeric GTP-Binding Proteins / physiology*
  • In Vitro Techniques
  • Male
  • Mesenteric Arteries / drug effects*
  • Myography
  • Piperidines / pharmacology*
  • Potassium Channels, Calcium-Activated / pharmacology*
  • Pyrazoles / pharmacology*
  • Rats
  • Rats, Wistar
  • Receptors, Cannabinoid / drug effects*
  • Rimonabant
  • Vasodilation / drug effects*
  • Vasodilation / physiology*

Substances

  • Calcium Channels
  • Camphanes
  • Cannabinoid Receptor Antagonists
  • Endothelium-Dependent Relaxing Factors
  • Piperidines
  • Potassium Channels, Calcium-Activated
  • Pyrazoles
  • Receptors, Cannabinoid
  • SR 144528
  • Cannabidiol
  • Heterotrimeric GTP-Binding Proteins
  • Calcium Chloride
  • Rimonabant